Financial Statements
Submitted by ETC Group on
Submitted by ETC Group on
Submitted by ETC Group on
Submitted by ETC Staff on
Pharmaceutical firms and biotech companies are approaching botanical gardens to buy samples of tropical plant diversity - a clear violation of the spirit - if not the law - of the Convention on Biological Diversity. The rights of farmers and indigenous peoples are being bypassed by corporate deals that make a mockery of the CBD's fundamental principles.
Submitted by ETC Staff on
RAFI reviews the context, issues, events and strategies leading up to the Fourth Technical Conference on Plant Genetic Resources in Leipzig, 17-23 June 1996. A 12 page document.
Submitted by ETC Staff on
Draft World Food Summit Declaration and Plan of Action Entrenches Food Insecurity – but the Debate is Far from Over
Submitted by ETC Staff on
Human Tissue Collection Initiatives by the U.S. Military; Colombian Indigenous Peoples' Cells in the U.S.; Accompanying maps showing cell collections inColombia and Papua New Guinea
Submitted by ETC Staff on
RAFI's survey of agricultural biodiversity reveals that 75% of ex situ genetic resources and technology are held in the North, while 83% of in-situ genetic resources and technology are held in the South. Multilateral regimes for agricultural biodiversity management must insure that proceeds from biodiversity benefits go to the South's farmers.
Submitted by ETC Staff on
ISSUE: Biodiversity prospecting is the exploration, extraction and screening of biological diversity and indigenous knowledge for commercially valuable genetic and biochemical resources. Bilateral bioprospecting agreements are sanctioned by the multilateral Convention on Biological Diversity. In the vast majority of cases, however, commercial bioprospecting agreements cannot be effectively monitored or enforced by source communities, countries, or by the Convention, and amount to little more than "legalized" bio-piracy.
Submitted by ETC Staff on
RAFI examines plant utility patents granted by the US Patent and Trademark Office from 1985 through mid-1995. Utility plant patenting is a threat to world food security; exceedingly broad patents on biological materials and the processes used to manipulate them are "locking up" new plant biotechnologies in the hands of a small number of corporations.
Submitted by ETC Staff on
This issue looks at biopiracy case studies around the world including super-sweet brazzein from Gabon; the Foundation for Ethnobiology in Thailand; Peruvian indigenous peoples' rejection of Washington University's ICBG project; and more. A detailed list of bioprospecting and biopiracy activities (as of early 1996) is also included.
Submitted by ETC Staff on
Submitted by ETC Group on
Submitted by ETC Group on
Submitted by ETC Staff on
Phytophtora infestans, also known as the "late potato blight" is the fungus that caused the Great Potato Famine of 1845-49. One hundred and fifty years later, the blight is back again in new and deadlier forms. Will governments muster the political will to wage a true war against hunger and food insecurity? A nine page document.
Submitted by ETC Staff on
A detailed examination of the impact of the US Plant Patent Act. Passed by the US Congress in 1930, the PPA is the world's oldest sui generis intellectual property system designed for the patenting of life forms.
Submitted by ETC Staff on
In the race to identify patent and commercialize human genes, scientists and their corporate partners are collecting DNA samples from remote island populations in the South Atlantic, Micronesia and the east China sea. This issue highlights Sequana's search for the "asthma gene" derived from DNA samples collected from the people of Tristan da Cunha.
Submitted by ETC Staff on
In 1995, Calgene commercialized a genetically modified rapeseed that produces the lauric fatty acid - a product derived traditionally from tropical oils Will Calgene's high-lauric rapeseed displace markets for coconut and palm kernel oil producers in the tropics?
Submitted by ETC Staff on
Privatization and patenting of microorganisms is encouraged by WTO TRIPs. RAFI examines the value of microbial markets and microbial biopiracy.
Submitted by ETC Staff on
Submitted by ETC Staff on
This document reviews the year-long controversy over Agracetus's species-wide patent on all genetically modified soybean varieties. In April 1994, with the support of 18 CSOs worldwide, RAFI announced it would formally challenge the patent at the European Patent Office. A summary of RAFI's opposition statement appears here. A 14 page document.
Find out more about ETC Group, or contact us.